Cargando…
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-converting enzyme 2 (ACE2)(1), could represent a new chemoprophylactic approach for COVID-19 that complements vaccination(2,3). However, the mechanisms that control the expression of ACE2 remain unclear. Here we...
Ejemplares similares
-
COVID-19 and liver transplantation: the jury is still out – Authors' reply
por: Webb, Gwilym J, et al.
Publicado: (2021) -
Determining risk factors for mortality in liver transplant patients with COVID-19
por: Webb, Gwilym J, et al.
Publicado: (2020) -
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients
por: Webb, Gwilym J., et al.
Publicado: (2021) -
SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes
por: Baldelli, Luke, et al.
Publicado: (2023) -
COVID-19 and liver disease: mechanistic and clinical perspectives
por: Marjot, Thomas, et al.
Publicado: (2021)